# Inocras

CancerVision compares tumor and normal DNA using whole-genome sequencing, with report support and trial matching.

Author: Kevin Wimer
Canonical URL: https://kevinwimer.com/companies/inocras/
Stable ID: 3340ac28-f483-4a86-bcaf-d2034338f17b
Revision: 8810d05c-7ddc-4267-9137-ccc9ea2fc1d9
Published: 2026-10-23T00:00:15.301Z
Updated: 2026-10-23T00:00:15.301Z
Reviewed: 2026-10-22

## Who this is for
For people comparing this service with their care team. Inclusion is not a recommendation or a finding that it is right for your cancer.

## Before ordering

1. Ask your clinician what whole-genome testing would add to the reports you already have.
2. Have pathology and Inocras confirm the specimen instructions. Do not arrange another biopsy just because a website lists a sample requirement.
3. Ask for the full patient price. The US patient page says these tests are not currently covered by health insurance.
4. Ask what germline findings may be reported and whether genetic counseling is appropriate.

More data can uncover useful findings. It can also leave you with findings that do not change treatment.

## Limits and context
Service details are reported by the linked provider unless noted. Confirm current access, requirements and costs directly. A company profile does not establish clinical benefit.

## Relationships and disclosures
No paid placement. I have no investment, advisory role, paid partnership or other financial relationship with the twelve companies in this initial directory.

## Sources
- [CancerVision provider information](https://inocras.com/cancer-provider/) — Inocras; official; checked 2026-10-22; Paired testing, sample requirements, ordering, turnaround and report support.
- [CancerVision patient information](https://inocras.com/cancer-patient/) — Inocras; official; checked 2026-10-22; Clinician ordering and stated US insurance limitations.

Organization website: https://inocras.com/

Information/access: [CancerVision patient information](https://inocras.com/cancer-patient/)

Service status: available

## Company facts
- **Test:** Paired tumor-normal whole-genome sequencing for solid tumors, with clinical-trial matching support. (Sources: inocras-providers)
- **Sample:** The provider page lists FFPE curls or slides plus a paired normal sample from blood or a buccal swab. Confirm the current collection instructions. (Sources: inocras-providers)
- **Timing:** Two weeks from receipt of the required samples at the lab, according to the provider page. (Sources: inocras-providers)
- **Ordering and payment:** Ordered by a healthcare provider. The patient page says US insurance does not currently cover its whole-genome tests. (Sources: inocras-patients)

Topics: 
Capabilities: tumor-testing, clinical-trials

Related record IDs: f7221927-6b87-4be3-9a7c-906768a192a5, 892119f9-0439-4e43-b467-66c99bc7be7c

Follow Kevin on X: https://x.com/kevinace

Educational information, not an individualized treatment recommendation.